CALGB 50401: A randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma.

作者: John Leonard , Sin-Ho Jung , Jeffrey L. Johnson , Nancy Bartlett , Kristie A. Blum

DOI: 10.1200/JCO.2012.30.15_SUPPL.8000

关键词:

摘要: 8000 Background: Lenalidomide (L) and rituximab (R) are active as single agents in follicular (FL) other B-cell lymphomas, although combination strategies have not been previously assessed a...

参考文章(0)